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Introduction
The medical use of synthetic polymers has a long
history. On the basis of many laboratory and clinical
investigations, there are polymers, which are considered
as biocompatible [1], for example: polyethylene (PET),
polypropylene (PP), polytetrafluoroethylene (PTFE)
and polysulfone (PSU). These polymers are also
biostable in the human body and have found wide
applications in the medical field. 
One of the polymers mentioned above, polysulfone,
possesses many favourable properties, like resistance
to oxidation and hydrolysis as well as excellent stability in
aqueous inorganic acids, alkalies and saline solutions [2].
Another outstanding property is its inertness in the
living body, enabling it to be used in practical devices
such as medical bottles, respiratory sets and dialysis
membranes [3-5]. 
Several other polymers have also been investigated,
i.e. polyvinylidene fluoride (PVDF) with improved
textile and biological parameters [6]. This polymer is
more resistant to hydrolysis and degradation in
comparison with PET. It has also been used in vascular
surgery for many years due to its improved biostability
and minimum tissue response [7]. PVDF is used in soft
tissue applications and as a suture material [8, 9]. 
The confirmed biocompatibility of such polymers is
a feature which allows them to be combined with
carbon fibres to obtain a biocomposite. Such a compo-
site promotes living tissue interaction due to advanta-
geous influence of carbon fibres on the living body,
previously presented in literature [10, 11]. Carbon fibres
have been applied in various fields of medicine. Carbon
strands and braids are used to reconstruct ligaments
and tendons, whereas carbon fabrics are used in the
treatment of tissue defects or as compounds in tissue
engineering. Carbon fibres have proved to be useful
materials in polymer composites, where transfer of
mechanical loads is necessary. Addition of carbon fibres
to polysulfone produces composite materials which are
used to manufacture different medical devices such as
plates, screws, joint replacements and bone implants [1,
2, 12, 13]. 
Designing of such biomaterial composites is mostly
oriented towards obtaining high-strength materials
whose Young’s modulus matches that of the replaced
tissue, though it is not the only goal. By using well-
known polymers reinforced with carbon fibres
differing in type and form, it is possible to obtain
implantable materials with controlled Young’s modulus,
strength and deformability fitted to surrounding
tissue. This is an important factor in the treatment of
all types of tissue. 
Carbon composites applied in the tissue treatment
exhibit a number of advantageous properties, such as
transparency to X-rays, the possibility to obtain
complex shapes as well as reduced implant sizes.
Moreover, the polymer composite materials are fully
compatible with modern diagnostic methods such as
computer aided tomography (CAT) and magnetic
resonance imaging (MRI) as they are not magnetic
[13]. All these features allow these materials to often
replace metallic implants. 
68 ANNALS OF TRANSPLANTATION Vol. 9, No. 1A (Suppl.), 2004
An in Vitro Study 
of Polymer-Based Composites
Bo¿ena Konieczna*, Marta B³a¿ewicz*, Barbara Czajkowska**
ANNALS OF TRANSPLANTATION, Vol. 9, No. 1A (Suppl.), 2004, pp. 68–71
Abstract:
Structures of most tissues in the human body can be simulated with fibrous composite materials. A major problem associated with designing
biocompatible composites for reconstruction of damaged or missing tissues is the ability to mimic such structures. The physical, chemical and
mechanical properties of composite materials should be similar to those of the native tissue. Another very important factor of polymer-based
fibrous composite materials, which can relatively easily be modified, is their surface microstructure. This surface microstructure depends on the
way of preparation, type of polymer matrix and kind of reinforcement. 
This work was aimed to determine the biological properties of composites obtained from carbon fibres and a polymer matrix, which can be used
as biomaterial in the reconstruction of cartilage tissue. Two types of samples made from short carbon fibres and two kinds of polymers were
tested. The samples were prepared by casting technique. MTT tests were carried out in the presence of hFOB-1.19-line human osteoblasts and
HS-5-line human fibroblasts. The results show differences in viability of living cells. 
Results of the work show significant differences in biocompatibility of pure polymers and composites with short carbon fibres. 
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The PTFE/PVDF/PP copolymer contains tetrafluoro-
ethylene, vinylidene fluoride as well as propylene
units. It is an interesting material, which can be
applied as a biocompatible carbon fibres composite.
The PTFE/PVDF/PP copolymer possesses a low
mechanical strength (0.5-0.8 MPa) and high elonga-
tion at break (ca. 100%). 
Polymers, such as PSU and the PTFE/PVDF/PP
copolymer, mixed with carbon fibres (depending on
the fibre content and distribution in the polymer
matrix) to obtain composites should be an ideal
material for structural implants, whose mechanical
properties are close to that of native tissue. However,
dispersion of carbon fibres in the polymer matrix
influences not only mechanical properties, but also
microstructure, magnetic and electric properties of the
materials. Another important property of composite
materials is the possibility to modify their micro-
structure and surface properties due to the intro-
duction of carbon fibres in polymer matrix varying in
amount and the kinds of surface functional groups
present. Such features of polymer composite materials
influence their biological properties. 
The aim of the work was to study biocompatibility
of two kinds of polymers and their composites with
short carbon fibres under in vitro conditions. 
Methods
Polysulfone (“PSU”, Mw 26 000, cat. no 37,429-6) and
poly (tetrafluoroethylene-co-vinylidene fluoride-co-
propylene) (“TFL”, cat. no 45, 458-3) were purchased
from Aldrich Chemical Comp. Inc. Milwaukee, USA.
Dichloromethane and acetone (POCH S.A., Gliwice,
Poland) were used to prepare polymer solutions.
Polymer samples, namely: KPSU (with polysulfone
matrix) and KTFL (with poly (tetrafluoroethylene-co-
vinylidene fluoride-co-propylene matrix) with frag-
mented FT-300 carbon fibres (no sizing, Soficar,
France) were prepared by the casting technique. Pure
cast polymers were the reference samples. The
materials were prepared in the form of discs, 20 mm in
diameter. The discs were UV sterilized. The cells used
for assessment of the materials were hFOB-1.19-line
human osteoblasts and HS-5-line human fibroblasts
(ATCC, University Boulevard, Manassas, Canada)
placed on the smooth surface of the samples. The level
of type I collagen produced from both types of cells
was determined by ELISA. The viability of fibroblasts
and osteoblasts was assayed through MTT. 
Results
SEM micrographs of initial and fragmented carbon
fibres are shown in Fig. 1. Schematic drawings of
samples of pure polymers and composites with short
carbon fibres are displayed in Fig 2. 
Results of in vitro studies are presented in Figs. 3, 4,
5 and 6. The bars represent percentage values of
fibroblast and osteoblast viability and the level of
collagen produced by these cells, assuming 100%
survival for control cells. Acceptable test error is 5%. 
Discussion
The highest viability of fibroblasts was observed on the
surface of pure polysulfone (Fig. 3). The corresponding
carbon fibre composite (KPSU) exhibited a viability
comparable to the samples of TFL. The PSU samples
were found to have the highest level of collagen
produced by these cells (Fig. 4). 
Investigation of TFL composite samples (KTFL)
showed that the level of collagen produced by fibro-
blasts on their surface is higher than on the surface of
reference samples (Fig. 4). Furthermore, despite the
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Figure 1. SEM micrographs of initial and fragmented carbon fibres, 50× and 500× magn.
Figure 2.
lower fibroblast viability, the cells interacting with the
composite samples produce more collagen (Fig. 3). 
Osteoblast viability (Fig. 5) is the highest in contact
with the KTFL surface. Viability of osteoblasts on KPSU is
about half of the reference sample (Fig. 5), but the level
of collagen produced on the composite is significantly
higher than on pure PSU (Fig. 6). This shows the favour-
able influence of carbon fibres on the biocompatibility of
the composite materials with osteoblasts. 
The results of biological investigations exhibit dif-
ferences in cell response depending on the type of poly-
mer. Both fibroblast and osteoblast viability differs with
the type of material. This could be understood as dif-
ferent biocompatibility of the investigated materials with
respect to different cells. Results presented in the work
indicate influence of composite materials on osteoblasts. 
The differences in viability and level of collagen
produced by the cells likely results from the different
surface energies of the investigated samples. The surface
energy of carbon-polymer composites is different from
pure polymers due to reaction of carbon fibre surfaces
with polymer functional groups. The results indicate
that osteoblasts, unlike fibroblasts, are sensitive to the
level of biomaterial surface energy. 
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Figure 3. Viability of fibroblasts on the surfaces of the examined
materials.
Figure 4. Levels of collagen (%) produced by fibroblasts on the examined
materials surfaces, normalized to the level of the control.
Figure 5. Viability of osteoblasts on the surfaces of the examined
materials.
Figure 6. Levels of collagen (%) produced by osteoblasts on the
examined material surfaces normalized to the level of the control.
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